CK Life Sciences Int'l. (Holdings) Crescita futura

Future criteri di controllo 0/6

Al momento non disponiamo di una copertura analitica sufficiente per prevedere la crescita e il fatturato di CK Life Sciences Int'l. (Holdings).

Informazioni chiave

n/a

Tasso di crescita degli utili

n/a

Tasso di crescita dell'EPS

Biotechs crescita degli utili	42.8%
Tasso di crescita dei ricavi	n/a
Rendimento futuro del capitale proprio	n/a
Copertura analitica	None
Ultimo aggiornamento	n/a

Aggiornamenti recenti sulla crescita futura

Nessun aggiornamento

Recent updates

CK Life Sciences Int'l., (Holdings) Inc.'s (HKG:775) Share Price Boosted 34% But Its Business Prospects Need A Lift Too

Oct 04

There's No Escaping CK Life Sciences Int'l., (Holdings) Inc.'s (HKG:775) Muted Revenues Despite A 32% Share Price Rise

May 03

CK Life Sciences Int'l. (Holdings)'s (HKG:775) Anemic Earnings Might Be Worse Than You Think

Apr 25

CK Life Sciences Int'l. (Holdings) (HKG:775) Use Of Debt Could Be Considered Risky

Mar 26

Here's Why CK Life Sciences Int'l. (Holdings) (HKG:775) Can Manage Its Debt Responsibly

Sep 27

Does CK Life Sciences Int'l. (Holdings) (HKG:775) Have A Healthy Balance Sheet?

Sep 16

Estimating The Intrinsic Value Of CK Life Sciences Int'l., (Holdings) Inc. (HKG:775)

Aug 21

These 4 Measures Indicate That CK Life Sciences Int'l. (Holdings) (HKG:775) Is Using Debt Extensively

Apr 14

CK Life Sciences Int'l., (Holdings) Inc. (HKG:775) Delivered A Weaker ROE Than Its Industry

Mar 18

If You Had Bought CK Life Sciences Int'l. (Holdings) (HKG:775) Shares Five Years Ago You'd Have Earned 45% Returns

Feb 01

What Kind Of Shareholders Hold The Majority In CK Life Sciences Int'l., (Holdings) Inc.'s (HKG:775) Shares?

Jan 04

CK Life Sciences Int'l. (Holdings) (HKG:775) Has A Somewhat Strained Balance Sheet

Dec 09

We Wouldn't Rely On CK Life Sciences Int'l. (Holdings)'s (HKG:775) Statutory Earnings As A Guide

Nov 18

In questa sezione di solito presentiamo le proiezioni di crescita dei ricavi e degli utili basate sulle stime di consenso degli analisti professionisti per aiutare gli investitori a capire la capacità della società di generare profitti. Tuttavia, poiché CK Life Sciences Int'l. (Holdings) non ha fornito dati sufficienti sul passato e non ha previsioni degli analisti, i suoi utili futuri non possono essere calcolati in modo affidabile estrapolando i dati passati o utilizzando le previsioni degli analisti.

Si tratta di una situazione piuttosto rara, dato che il 97% delle società coperte da SimplyWall St dispone di dati finanziari passati.

Previsioni di crescita degli utili e dei ricavi

SEHK:775 - Stime future degli analisti e dati finanziari passati (HKD Millions )
Data	Ricavi	Guadagni	Flusso di cassa libero	Liquidità dell'operazione	Avg. Numero di analisti
6/30/2024	5,379	-19	418	579	N/A
3/31/2024	5,351	-1	385	547	N/A
12/31/2023	5,323	17	353	514	N/A
9/30/2023	5,318	61	191	372	N/A
6/30/2023	5,314	104	100	230	N/A
3/31/2023	5,295	118	137	297	N/A
12/31/2022	5,276	132	175	364	N/A
9/30/2022	5,290	130	302	486	N/A
6/30/2022	5,305	128	430	608	N/A
3/31/2022	5,353	145	318	516	N/A
12/31/2021	5,402	163	206	424	N/A
9/30/2021	5,302	150	107	429	N/A
6/30/2021	5,201	138	7	435	N/A
3/31/2021	5,072	132	79	483	N/A
12/31/2020	4,943	125	151	531	N/A
9/30/2020	4,846	112	139	433	N/A
6/30/2020	4,750	98	128	335	N/A
3/31/2020	4,859	140	155	357	N/A
12/31/2019	4,967	182	181	379	N/A
9/30/2019	5,128	223	90	337	N/A
6/30/2019	5,288	263	-1	295	N/A
3/31/2019	5,261	263	-29	263	N/A
12/31/2018	5,233	263	-57	231	N/A
9/30/2018	5,077	261	N/A	N/A	N/A
6/30/2018	4,920	259	165	237	N/A
3/31/2018	4,807	259	N/A	186	N/A
12/31/2017	4,693	258	N/A	135	N/A
9/30/2017	4,674	247	N/A	N/A	N/A
6/30/2017	4,655	236	N/A	352	N/A
3/31/2017	4,762	244	N/A	396	N/A
12/31/2016	4,869	253	N/A	439	N/A
9/30/2016	4,933	240	N/A	N/A	N/A
6/30/2016	4,998	228	N/A	314	N/A
3/31/2016	4,959	223	N/A	309	N/A
12/31/2015	4,919	219	N/A	304	N/A
9/30/2015	4,953	257	N/A	N/A	N/A
6/30/2015	4,987	296	N/A	263	N/A
3/31/2015	4,970	280	N/A	294	N/A
12/31/2014	4,954	264	N/A	325	N/A
9/30/2014	4,930	250	N/A	312	N/A
6/30/2014	4,907	236	N/A	300	N/A
3/31/2014	4,939	232	N/A	283	N/A
12/31/2013	4,971	229	N/A	267	N/A

Previsioni di crescita futura degli analisti

Guadagni vs tasso di risparmio: Dati insufficienti per determinare se la crescita degli utili prevista 775 è superiore al tasso di risparmio ( 2.3% ).

Guadagni vs Mercato: Dati insufficienti per determinare se si prevede che gli utili di 775 cresceranno più velocemente del mercato Hong Kong

Guadagni ad alta crescita: Dati insufficienti per determinare se si prevede che gli utili di 775 cresceranno in modo significativo nei prossimi 3 anni.

Ricavi vs Mercato: Dati insufficienti per determinare se si prevede che i ricavi di 775 cresceranno più rapidamente del mercato Hong Kong.

Ricavi ad alta crescita: Dati insufficienti per determinare se si prevede che i ricavi di 775 cresceranno più rapidamente di 20% all'anno.

Previsioni di crescita dell'utile per azione

Rendimento futuro del capitale proprio

ROE futuro: Dati insufficienti per determinare se il Return on Equity di 775 è previsto essere elevato tra 3 anni

CK Life Sciences Int'l. (Holdings) Crescita futura

Future criteri di controllo 0/6

Informazioni chiave

Aggiornamenti recenti sulla crescita futura

Recent updates

VP, CEO & Executive Director recently bought HK$969k worth of stock

Now 21% undervalued

CK Life Sciences Int'l., (Holdings) Inc.'s (HKG:775) Share Price Boosted 34% But Its Business Prospects Need A Lift Too

CK Life Sciences Int'l., (Holdings) Inc Announces Director Changes

First half 2024 earnings released: EPS: HK$0 (vs HK$0.004 in 1H 2023)

CK Life Sciences Int'l., (Holdings) Inc. to Report First Half, 2024 Results on Aug 13, 2024

There's No Escaping CK Life Sciences Int'l., (Holdings) Inc.'s (HKG:775) Muted Revenues Despite A 32% Share Price Rise

CK Life Sciences Int'l. (Holdings)'s (HKG:775) Anemic Earnings Might Be Worse Than You Think

Full year 2023 earnings released: EPS: HK$0.002 (vs HK$0.014 in FY 2022)

CK Life Sciences Int'l. (Holdings) (HKG:775) Use Of Debt Could Be Considered Risky

CK Life Sciences Int'l., (Holdings) Inc., Annual General Meeting, May 23, 2024

Full year 2023 earnings released: EPS: HK$0.002 (vs HK$0.014 in FY 2022)

New minor risk - Financial data availability

CK Life Sciences Int'l., (Holdings) Inc. to Report Fiscal Year 2023 Results on Mar 19, 2024

Ck Life Sciences Int'l., (Holdings) Inc. Announces Preclinical Data for Its Investigational Dual-Antigen Cancer Vaccines, Co-Targeting Prame and PD-L1

First half 2023 earnings released: EPS: HK$0.004 (vs HK$0.007 in 1H 2022)

Now 21% undervalued

Full year 2022 earnings released: EPS: HK$0.014 (vs HK$0.017 in FY 2021)

Less than half of directors are independent

Here's Why CK Life Sciences Int'l. (Holdings) (HKG:775) Can Manage Its Debt Responsibly

CK Life Sciences Int'l., (Holdings) Inc. Announces Retirement of Independent Non-Executive Director and Change in Composition of the Remuneration Committee

First half 2022 earnings released

CK Life Sciences Int'l., (Holdings) Inc. to Report First Half, 2022 Results on Aug 02, 2022

Investor sentiment improved over the past week

Upcoming dividend of HK$0.01 per share

Less than half of directors are independent

Full year 2021 earnings: EPS exceeds analyst expectations while revenues lag behind

CK Life Sciences Int'l., (Holdings) Inc. to Report Fiscal Year 2021 Results on Mar 15, 2022

Now 20% undervalued after recent price drop

Does CK Life Sciences Int'l. (Holdings) (HKG:775) Have A Healthy Balance Sheet?

First half 2021 earnings released: EPS HK$0.01 (vs HK$0.009 in 1H 2020)

Estimating The Intrinsic Value Of CK Life Sciences Int'l., (Holdings) Inc. (HKG:775)

Upcoming dividend of HK$0.01 per share

Full year 2020 earnings released: EPS HK$0.013 (vs HK$0.019 in FY 2019)

These 4 Measures Indicate That CK Life Sciences Int'l. (Holdings) (HKG:775) Is Using Debt Extensively

CK Life Sciences Int'l., (Holdings) Inc. (HKG:775) Delivered A Weaker ROE Than Its Industry

Full year 2020 earnings released: EPS HK$0.013 (vs HK$0.019 in FY 2019)

Ck Life Sciences Int'l., (Holdings) Inc. Recommends Final Dividend for the Year Ended 31 December 2020, Payable on May 31, 2021

CK Life Sciences Int'l., (Holdings) Inc. to Report Fiscal Year 2020 Results on Mar 16, 2021

If You Had Bought CK Life Sciences Int'l. (Holdings) (HKG:775) Shares Five Years Ago You'd Have Earned 45% Returns

What Kind Of Shareholders Hold The Majority In CK Life Sciences Int'l., (Holdings) Inc.'s (HKG:775) Shares?

CK Life Sciences Int'l. (Holdings) (HKG:775) Has A Somewhat Strained Balance Sheet

We Wouldn't Rely On CK Life Sciences Int'l. (Holdings)'s (HKG:775) Statutory Earnings As A Guide

New 90-day low: HK$0.86

CK Life Sciences Int'l., (Holdings) Inc. Announces Directors Changes

New 90-day low: HK$0.89

CK Life Sciences Int'l., (Holdings) Inc. Announces Executive Changes

First half earnings released

CK Life Sciences Int'l., (Holdings) Inc. to Report Q2, 2020 Results on Aug 04, 2020

Previsioni di crescita degli utili e dei ricavi

Previsioni di crescita futura degli analisti

Previsioni di crescita dell'utile per azione

Rendimento futuro del capitale proprio

Scoprire le aziende in crescita